Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan - Drugs.com MedNews
Links shared publicly online about this topic.
- 217total visits
Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan - Drugs.com MedNews
Osaka, Japan, June 15, 2011 Takeda Pharmaceutical Company Limited ( Takeda ) announced today that it will initiate the phase III clinical trial in Japan of the
View full resource at drugs.com
Tags: Vaccination, Drug, Pharma, Clinical Trial, Vaccine
Most Recently Shared on June 15, 2011 at 4:18 pm By:
Hib Vaccine TAK-816 Enters into the Phase III Clinical Trial in Japan: Osaka, Japan, June 15, 2011 – Taked... http://bit.ly/mMMj1K #drug
Advertisement
